Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Schwetz, V; Eisner, F; Schilcher, G; Eller, K; Plank, J; Lind, A; Pieber, TR; Mader, JK; Eller, P.
Combined metformin-associated lactic acidosis and euglycemic ketoacidosis.
Wien Klin Wochenschr. 2017; 129(17-18):646-649 Doi: 10.1007/s00508-017-1251-6 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Leading authors Med Uni Graz
Mader Julia
Theiler-Schwetz Verena
Co-authors Med Uni Graz
Eisner Florian
Eller Kathrin
Eller Philipp
Lind Alice Florentina
Pieber Thomas
Schilcher Gernot
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: In renal failure metformin can lead to lactic acidosis. Additional inhibition of hepatic gluconeogenesis by accumulation of the drug may aggravate fasting-induced ketoacidosis. We report the occurrence of metformin-associated lactic acidosis (MALA) with concurrent euglycemic ketoacidosis (MALKA) in three patients with renal failure. CASE PRESENTATIONS: Patient 1: a 78-year-old woman (pH = 6.89, lactic acid 22 mmol/l, serum ketoacids 7.4 mmol/l and blood glucose 63 mg/dl) on metformin and insulin treatment. Patient 2: a 79-year-old woman on metformin treatment (pH = 6.80, lactic acid 14.7 mmol/l, serum ketoacids 6.4 mmol/l and blood glucose 76 mg/dl). Patient 3: a 71-year-old man on metformin, canagliflozin and liraglutide treatment (pH = 7.21, lactic acid 5.9 mmol/l, serum ketoacids 16 mmol/l and blood glucose 150 mg/dl). In all patients, ketoacidosis receded on glucose infusion and renal replacement therapy. CONCLUSION: This case series highlights the parallel occurrence of MALA and euglycemic ketoacidosis, the latter exceeding ketosis due to starvation, suggesting a metformin-triggered inhibition of gluconeogenesis. Affected patients benefit from glucose infusion counteracting suppressed hepatic gluconeogenesis.
Find related publications in this database (using NLM MeSH Indexing)
Acidosis, Lactic - chemically induced
Aged - administration & dosage
Blood Glucose - metabolism
Canagliflozin - adverse effects, therapeutic use
Diabetes Mellitus, Type 2 - blood, drug therapy
Drug Therapy, Combination - administration & dosage
Female - administration & dosage
Gluconeogenesis - drug effects
Humans - administration & dosage
Insulin - adverse effects, therapeutic use
Ketosis - chemically induced
Kidney Failure, Chronic - complications
Liraglutide - adverse effects, therapeutic use
Male - administration & dosage
Metformin - adverse effects, therapeutic use

Find related publications in this database (Keywords)
Ketoacidosis
Type 2 diabetes
Metformin
Lactic acidosis
© Med Uni GrazImprint